✦ LIBER ✦
Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups
✍ Scribed by Amadori, S; Suciu, S; Stasi, R; Willemze, R; Mandelli, F; Selleslag, D; Denzlinger, C; Muus, P; Stauder, R; Berneman, Z
- Book ID
- 110056422
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 113 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.